The correlation of mean platelet volume and neutrophil-lymphocyte ratio measurements, and the Ishak fibrosis score in our patients with chronic hepatitis B
Correlation of mean platelet volume and neutrophil-lymphocyte ratio measurements
Keywords:Hepatitis B virus, MPV, NLR, Ishak fibrosis score
Background:The ishak score determined by liver biopsy is the most reliable indicator of fibrosis, but biopsy is an invasive procedure. Numerous noninvasive tests have been investigated to determine the hepatic fibrosis score. We aimed to investigate the relationship between the mean platelet volume(MPV) and neutrophillymphocyte ratio (NLR) measurements in patients with chronic hepatitis B virus (CHB) infection, and liver fibrosis stage, which was determined by biopsy and ishak score.
Material and Method:CHB patients followed between 2016 and 2020 in our gastroenterology outpatient clinic were included in our study. CHB patients; They were divided into two groups as non-cirrhotic group (ishak fibrosis score in biopsy; F0-F4) and cirrhotic group (F5-F6). Then, 30 healthy control (HC) groups consisting of health personnel who had routine health screenings and blood tests in the same period were formed. MPV, NLR measurements of these two main groups and CHB subgroups and liver biopsy results of CHB patients were evaluated retrospectively, and possible relationships between the groups were investigated.
Results:There was no statistically significant difference between the mean age and gender of the cases in the CHB and HC groups. A total of 54 patients with CHB were identified, of which 13 patients were cirrhotic and 41 patients were non-cirrhotic. MPV measurements were found to be significantly higher in the CHB group than in the SC group (11.15±1.77; 10.02±0.92; p=0.002). While there was no significant difference between NLR measurements, it was found to be higher in the CHB group (1.98±0.81; 1.81±0.69). While there was no significant difference between the cirrhotic and non-cirrhotic subgroups of the CHB group in terms of NLR (1.86±0.68; 2.36±1.04) and MPV (11.09±1.89; 11.35±1.36) measurements, NLR and MPV measurements were higher in the cirrhotic group.
Conclusion:In our study, MPV values were found to be significantly increased in patients in the CHB group compared to the HC group. In addition, although not statistically significant, NLR and MPV measurements were found to be higher in the cirrhotic group than in the non-cirrhotic group. According to our study, it can be thought that with increasing MPV and NLR measurements in HBV patients, there may be an increase in chronicity and fibrosis scores without an invasive procedure such as biopsy.
Afdhal NH, Nunes D. Evaluation of liver fibrosis: A concise review. Am J Gastroenterol 2004; 99:1160-1174.
Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France:Results of a prospective nationwide survey for the group of epidemiology of the French association for the study of the liver (AFEF). Hepatology 2000; 32477–481.
Friedman SL. Liver fibrosis from bench to bedside. J Hepatol 2003; 38:S38–S53.
Ekiz F. et al. Mean platelet volume as a fibrosis marker in patients with chronic hepatitis B. J Clin Lab Anal. 2011; 25(3): 162–165.
Ishak K, Baptista A, Bianchi L, Callea F, De GJ et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995 Jun; 22(6): 696–699.
Everhat JE et al. Prognostic Value of Ishak Fibrosis Stage: Findings from the HALT-C Trial. Hepatology. 2010 February; 51(2).
Söker G et al. The Value of Fibrosis Index in Discrimination of Chronic Hepatitis and Cirrhosis. Med Bull Haseki 2017; 55: 212-5.
Rodak AP, Kiciak S, Tomasiewicz K. Neutrophil-lymphocyte ratio and mean platelet volume as predictive factors for liver fibrosis. Annals of Agricultural and Environmental Medicine 2018, Vol 25, No 4.
Fan Y, Li X, Zhou XF et al. Value of neutrophil-lymphocyte ratio in predicting hepatitis B-related liver failure. Zhonghua Gan Zang Bing Za Zhi 2017; 25: 726–731.
Lee HH, Seo YS, Um SH et al. Usefulness of non‐invasive markers for predicting significant fibrosis in patients with chronic liver disease.J Korean Med Sci 2010; 25: 67-74.
Bath PM, Butterworth RJ. Platelet size: measurement, physiology and vascular disease.Blood Coagul Fibrinolysis 1996; 7:157-161.
Bath P, Algert C, Chapman N, Neal B. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease.Stroke. 2004; 35: 622–626.
Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost. 2010; 8:148–156.
Lee WS, Kim TY. Alcoholic fatty liver disease and alcoholic liver cirrhosis may be differentiated with mean platelet volume and platelet distribution width.Platelets. 2010; 21: 584–585.
Turhan O, Coban E, Inan D, Yalcin AN. Increased mean platelet volume in chronic hepatitis B patients with inactive disease. Med Sci Monit.2010; 16: CR202–205.
Ozhan H, Aydin M, Yazici M, Yazgan O, Basar C, Gungor A et al. Mean platelet volume in patients with non-alcoholic fatty liver disease. Platelets. 2010; 21: 29–32.
Hu Y, Lou Y, Chen Y, Mao W. Evaluation of mean platelet volume in patients with hepatitis B virus infection. Int J Clin Exp Med. 2014; 7(11): 4207–4213.
Zhang H, Sun, Q, Mao W, Fan J, Ye B. Neutrophil-to-Lymphocyte Ratio Predicts Early Mortality in Patients with HBV-Related Decompensated Cirrhosis. Gastroenterology Research and Practice. 02 Feb 2016. Volume 2016, Article ID 4394650.
Chen L, Lou Y, Chen Y, Yang J. Prognostic value of the neutrophil-to-lymphocyte ratio in patients with acute-on-chronic liver failure. International Journal of Clinical Practice, vol. 68, no. 8, pp. 1034–1040, 2014.
Liu H, Zhang H, Wan G. et al. Neutrophil–lymphocyte ratio: a novel predictor for short-term prognosis in acute-on-chronic hepatitis B liver failure. Journal of Viral Hepatitis, vol. 21, no. 7, pp. 499–507, 2014.
Biyik M, Ucar R, Solak Y. et al. Blood neutrophil to lymphocyte ratio independently predicts survival in patients with liver cirrhosis. European Journal of Gastroenterology and Hepatology, vol. 25, no. 4, pp. 435–441, 2013.
Halazun KJ, Hardy MA, Rana AA et al. Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Ann Surg 2009; 250: 141-151.
Lee HW, Kyung-Suk S. Liver transplantation for advanced hepatocellular carcinoma. Clin Mol Hepatol. 2016; 22(3): 309-318.
Everhart JE et al. Prognostic Value of Ishak Fibrosis Stage: Findings from the HALT-C Trial. Hepatology. 2010 Feb; 51(2):10.1002/hep.23315.
Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France:Results of a prospective nationwide survey for the group of epidemiology of the French association for the study of the liver (AFEF). Hepatology 2000; 32:477-481.
Maharaj B, Maharaj RJ, Leary WP et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986; 1: 523– 525.
Bulur A, Cakir AS. NLR, MPV and RDW as Biomarkers in Operated and Non-operated Patients with Colorectal Adenocarcinoma. Bagcilar Med Bull 2021;6:314-319.
Topal K, Bingöl F, Kars A, Atalay F (2021). Mean platelet volume and red cell distribution width values in children with recurrent epistaxis. Kastamonu Medical Journal, 1(4), 90–92.
How to Cite
Copyright (c) 2022 Kastamonu Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.